Introduction The aim of the research is to evaluate the clinical outcome among moderate-severe COVID-19 patients treated with standard drug
therapy plus LMW Heparin as compared to those not given LMW Heparin. It has several objectives such as to evaluate the clinical outcome among
moderate-severe COVID-19 patients admitted to RUHS-HMS and treated with LMW Heparin along with Standard Treatment Protocol by
assessing their in-hospital course of illness, duration of hospital stays, recovery, and mortality. To identify the possible risk factors associated with
COVID Patients. Methods A retrospective, observational study is undertaken. The study is conducted in the hospital attached to RUHS College of
medical sciences, Jaipur, Rajasthan. The study is conducted over a period of eight months. The data which is achieved from the study isanalyzed
statistically. For this, the usage of SPSS version 17.0 software is done. The test which is used is the standard deviation. The normal distribution of
the continuous variables between the groups isanalyzed with the help of a t-test the signicance level is set up at less than 0.05. ResultsIt revealed
that the adminstration of heparin was associated with lower mortality in patients admitted with COVID-19 as in group A patients who received
LMW Heparin, mortality was 11% with or without comorbidities whereas in group B it was found 18.68%. The presence of the disease is found to be associated with several other underlying conditions like liver, cardiovascular, kidney disease, and others. Conclusion It is concluded that the heparin usage is helpful and effective while treating the infection of COVID-19. Moreover, it is accountable for declining the rate of mortality in the patients. The current study also states that the underlying cardiovascular diseases are responsible for increasing the threat of mortality in patients who are suffering from COVID-19.
Background
Primary nerve sheath tumor of cranial nerve is a rare intracranial space occupying lesion that most commonly involves vestibular nerve. Oculomotor nerve schwannoma, without neurofibromatosis, is an extremely uncommon entity especially in children. Though any cranial nerve can be involved by schwannoma except I and II nerve as these cranial nerves lack a Schwann cell sheath.
Case presentation
We herein report a 14-year-old boy presenting with an oculomotor schwannoma in the absence of features of neurofibromatosis, manifesting as progressive diplopia, ptosis, and blurring of vision.
Conclusions
Most similar previous case reports in literature reported oculomotor schwannoma in adults, unlike our case. The detection rate of such rare lesions has, however, increased in the last two decades due to neuroimaging advances.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.